Monday, July 17, 2017 5:16:36 PM
to get the whole story, you should speak with Matthew Henninger, bluesphere's IR person in NYC 212 355 5134.
btw...if i understand correctly, no PR's are allowed until offerings are closed. they ARE allowed to do 8k's and other SEC-docs however, which i believe they did re the RI plant startup recently as well as the purchase of the 2 add'l italian facilities...
the strictness re PR's right now is a shame as there appears to be a TON in the works, but unless it is definitive and can be 8-k'd, bluesphere's lawyers prohibit anything that could be construed as trying to boost sale of new stock. a bit of a catch-22, but management is right to follow their lawyers advice re this. last thing we want is any trouble with SEC and NASDAQ !!
agree it's frustrating for all concerned in the meantime, but we should be nearing the end of this crappy period. call henninger for more....
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM